769 related articles for article (PubMed ID: 11331952)
41. Expression of Aurora kinases A and B in normal, hyperplastic, and malignant human endometrium: Aurora B as a predictor for poor prognosis in endometrial carcinoma.
Kurai M; Shiozawa T; Shih HC; Miyamoto T; Feng YZ; Kashima H; Suzuki A; Konishi I
Hum Pathol; 2005 Dec; 36(12):1281-8. PubMed ID: 16311121
[TBL] [Abstract][Full Text] [Related]
42. Retinoblastoma protein expression in endometrial hyperplasia and carcinoma.
Niemann TH; Yilmaz AG; McGaughy VR; Vaccarello L
Gynecol Oncol; 1997 May; 65(2):232-6. PubMed ID: 9159330
[TBL] [Abstract][Full Text] [Related]
43. GLUT-1 is preferentially expressed in atypical endometrial hyperplasia and endometrial adenocarcinoma.
Ashton-Sager A; Paulino AF; Afify AM
Appl Immunohistochem Mol Morphol; 2006 Jun; 14(2):187-92. PubMed ID: 16785788
[TBL] [Abstract][Full Text] [Related]
44. The retinoblastoma-related Rb2/p130 gene is an effector downstream of AP-2 during neural differentiation.
Paggi MG; Bonetto F; Severino A; Baldi A; Battista T; Bucci F; Felsani A; Lombardi D; Giordano A
Oncogene; 2001 May; 20(20):2570-8. PubMed ID: 11420667
[TBL] [Abstract][Full Text] [Related]
45. [Expression of receptor-binding cancer antigen expressed on SiSo cells in endometrial carcinoma and the correlation thereof with the expression of estrogen receptor subtypes].
Zhou XH; Xu ST; Song WY; Teng XD
Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(27):1900-3. PubMed ID: 17923013
[TBL] [Abstract][Full Text] [Related]
46. Expression of replication-licensing factors MCM2 and MCM3 in normal, hyperplastic, and carcinomatous endometrium: correlation with expression of Ki-67 and estrogen and progesterone receptors.
Kato K; Toki T; Shimizu M; Shiozawa T; Fujii S; Nikaido T; Konishi I
Int J Gynecol Pathol; 2003 Oct; 22(4):334-40. PubMed ID: 14501812
[TBL] [Abstract][Full Text] [Related]
47. Leukaemia inhibitory factor (LIF) is immunohistochemically expressed in normal, hyperplastic and malignant endometrial tissue.
Mylonas I; Makovitzky J; Shabani N; Richter DU; Kuhn C; Jeschke U; Briese V; Friese K
Eur J Obstet Gynecol Reprod Biol; 2005 Jan; 118(1):101-8. PubMed ID: 15596282
[TBL] [Abstract][Full Text] [Related]
48. Tumor-specific exon 1 mutations could be the 'hit event' predisposing Rb2/p130 gene to epigenetic silencing in lung cancer.
Cinti C; Macaluso M; Giordano A
Oncogene; 2005 Sep; 24(38):5821-6. PubMed ID: 16044156
[TBL] [Abstract][Full Text] [Related]
49. Nuclear and cytoplasmic bcl-2 expression in endometrial hyperplasia and adenocarcinoma.
Chan WK; Mole MM; Levison DA; Ball RY; Lu QL; Patel K; Hanby AM
J Pathol; 1995 Nov; 177(3):241-6. PubMed ID: 8551385
[TBL] [Abstract][Full Text] [Related]
50. Nuclear localization of beta-catenin in normal and carcinogenic endometrium.
Nei H; Saito T; Yamasaki H; Mizumoto H; Ito E; Kudo R
Mol Carcinog; 1999 Jul; 25(3):207-18. PubMed ID: 10411147
[TBL] [Abstract][Full Text] [Related]
51. Detection of chromosomal anomalies in endometrial atypical hyperplasia and carcinoma by using fluorescence in situ hybridization.
Qian J; Weber D; Cochran R; Hossain D; Bostwick DG
Cancer Cytopathol; 2010 Apr; 118(2):97-104. PubMed ID: 20225199
[TBL] [Abstract][Full Text] [Related]
52. Genetic imbalances in endometrial hyperplasia and endometrioid carcinoma detected by comparative genomic hybridization.
Muslumanoglu HM; Oner U; Ozalp S; Acikalin MF; Yalcin OT; Ozdemir M; Artan S
Eur J Obstet Gynecol Reprod Biol; 2005 May; 120(1):107-14. PubMed ID: 15866096
[TBL] [Abstract][Full Text] [Related]
53. [A comparative morphometric and DNA content study of endometrial hyperplasia and adenocarcinoma].
Zhou XR; Du XG
Zhonghua Fu Chan Ke Za Zhi; 1992 Sep; 27(5):278-80, 316. PubMed ID: 1298588
[TBL] [Abstract][Full Text] [Related]
54. Significance of matrix metalloproteinase-7 [correction of matrix metalloproteinase-2], -11 and tissue inhibitor of metalloproteinase-1 expression in normal, hyperplastic and neoplastic endometrium.
Obokata A; Watanabe J; Nishimura Y; Arai T; Kawaguchi M; Kuramoto H
Anticancer Res; 2007; 27(1A):95-105. PubMed ID: 17352221
[TBL] [Abstract][Full Text] [Related]
55. Oestrogen and progesterone receptor immunocytochemistry in human hyperplastic and neoplastic endometrium.
Snijders MP; de Goeij AF; Koudstaal J; Thunnissen EB; de Haan J; Bosman FT
J Pathol; 1992 Feb; 166(2):171-7. PubMed ID: 1560318
[TBL] [Abstract][Full Text] [Related]
56. Differential diagnosis of endometrial hyperplasia and carcinoma by computerized image cytometry of cell proliferation, apoptosis and Bcl-2 expression.
Mora LB; Diaz JI; Cantor AB; Nicosia SV
Ann Clin Lab Sci; 1999; 29(4):308-15. PubMed ID: 10528831
[TBL] [Abstract][Full Text] [Related]
57. Expression and prognostic significance of urokinase and plasminogen activator inhibitor type-1 in endometrial hyperplasia and cancer.
Taponeco F; Curcio C; Giuntini A; Nardini V; Fornaciari G; Artini PG; D'Ambrogio G; Genazzani AR
J Exp Clin Cancer Res; 2001 Jun; 20(2):239-46. PubMed ID: 11484981
[TBL] [Abstract][Full Text] [Related]
58. [Genetic alterations and transformations in development and establishment of uterine endometrial carcinomas].
Inoue M
Nihon Sanka Fujinka Gakkai Zasshi; 1993 Aug; 45(8):751-62. PubMed ID: 8371006
[TBL] [Abstract][Full Text] [Related]
59. Mutations in the retinoblastoma-related gene RB2/p130 in primary nasopharyngeal carcinoma.
Claudio PP; Howard CM; Fu Y; Cinti C; Califano L; Micheli P; Mercer EW; Caputi M; Giordano A
Cancer Res; 2000 Jan; 60(1):8-12. PubMed ID: 10646842
[TBL] [Abstract][Full Text] [Related]
60. RB and RB2/p130 genes demonstrate both specific and overlapping functions during the early steps of in vitro neural differentiation of marrow stromal stem cells.
Jori FP; Melone MA; Napolitano MA; Cipollaro M; Cascino A; Giordano A; Galderisi U
Cell Death Differ; 2005 Jan; 12(1):65-77. PubMed ID: 15459751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
